Bridgewater Associates (Ray Dalio) — ALNY Trade History
Quarter-by-quarter changes in the ALNYLAM PHARMACEUTICALS INC position · CUSIP 02043Q107
Currently held · 1 YearFirst seen: 2021 Q2
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 99,584 | -7,008 | -6.6% | $30.0M | 0.12% |
| 2026 Q1 | 2026-05-15 | Add | 106,592 | 20,975 | +24.5% | $35.3M | 0.16% |
| 2025 Q4 | 2026-02-13 | Add | 85,617 | 51,706 | +152.5% | $34.0M | 0.12% |
| 2025 Q3 | 2025-11-13 | New | 33,911 | 33,911 | — | $15.5M | 0.06% |
| 2025 Q2 | 2025-08-13 | — | — | — | — | — | — |
| 2025 Q1 | 2025-05-14 | Sold out | — | -6,452 | -100.0% | — | — |
| 2024 Q4 | 2025-02-13 | Add | 6,452 | 4,450 | +222.3% | $1.5M | 0.01% |
| 2024 Q3 | 2024-11-13 | New | 2,002 | 2,002 | — | $550.6K | 0.00% |
| 2024 Q2 | 2024-08-14 | — | — | — | — | — | — |
| 2024 Q1 | 2024-05-14 | Sold out | — | -1,951 | -100.0% | — | — |
| 2023 Q4 | 2024-02-14 | Add | 1,951 | 65 | +3.4% | $373.4K | 0.00% |
| 2023 Q3 | 2023-11-13 | Add | 1,886 | 90 | +5.0% | $334.0K | 0.00% |
| 2023 Q2 | 2023-08-11 | Add | 1,796 | 541 | +43.1% | $341.1K | 0.00% |
| 2023 Q1 | 2023-05-12 | New | 1,255 | 1,255 | — | $251.4K | 0.00% |
| 2022 Q4 | 2023-02-13 | Sold out | — | -1,283 | -100.0% | — | — |
| 2022 Q3 | 2022-11-10 | Reduce | 1,283 | -229 | -15.1% | $257.0K | 0.00% |
| 2022 Q2 | 2022-08-11 | New | 1,512 | 1,512 | — | $221.0K | 0.00% |
| 2022 Q1 | 2022-05-13 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-14 | Sold out | — | -2,234 | -100.0% | — | — |
| 2021 Q3 | 2021-11-12 | Reduce | 2,234 | -3,865 | -63.4% | $422.0K | 0.00% |
| 2021 Q2 | 2021-08-13 | New | 6,099 | 6,099 | — | $1.0M | 0.01% |
| 2021 Q1 | 2021-05-14 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-12 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-13 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-13 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-13 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-14 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-13 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q1 | 2018-08-13 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-13 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-13 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-13 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-11 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-10 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.